Iowa Admin. Code r. 521-1.1
The livestock health advisory council recommends that this appropriation for fiscal year 1999-2000 be applied in the following manner.
| ILHAC Projects Approved for 1999-2000 | ||
| 1. | The role of immediate hypersensitivity in Haemophilus somnus-induced bovine respiratory disease | $20,000 |
| 2. | Investigation into the prevalence of H3N2 swine influenza virus infections in U.S. swine | $20,000 |
| 3. | Specific effect of PrP scrapie on types of brain cells | $15,000 |
| 4. | Gene discovery in veterinary mycoplasmal pathogens | $20,000 |
| 5. | Antigenic characterization of PRRS virus isolates associated with acute PRRS and vaccination failure | $20,000 |
| 6. | Prevention and control of turkey rhinotracheitis (TRT): development of an inactivated vaccine | $18,000 |
| 7. | Efficacy of a vaccine in control of Johne’s disease in cattle | $17,940 |
| 8. | Potential effects of epizootic hemorrhagic disease on Iowa cattle | $12,500 |
| 9. | Treatment and prevention of cryptosporidiosis of calves: screening of potential anti-cryptosporidial compounds in mice and calves | $20,000 |
| 10. | Development of immunoprophylaxis for the prevention and control of bovine papillomatous digital dermatitis (hairy heel wart) | $19,500 |
| 11. | Are granulocyte adapted Salmonella vaccines host species specific? | $15,920 |
| 12. | Impact of sulfate, dissolved solids, iron, and other drinking water quality parameters to on-farm performance and health of dairy cattle in Iowa: implications for dairy industry | $10,000 |
| 13. | Assessing the role of porcine circovirus I postweaning multisystemic wasting syndrome (PMWS) using a case-control study | $18,000 |
| 14. | Bacteriological and serological survey of commercial chicken laying hens flocks for Ornithobacterium rhinotracheale | $7,000 |
| 15. | Mycoplasma hyopneumoniae: comparison of immunological responses to vaccination and/or challenge in pigs with or without maternal antibodies | $18,000 |
| 16. | Transformation of Mycoplasma bovis as an aid in identification of virulence factors | $15,000 |
| Contingency Funds | $10,713 | |
| Total | $277,573 |